February 7, 2012

2010 Cancer Immunotherapy: A Long-Awaited Reality

Cancer Immunotherapy: A Long-Awaited Reality conference, October 21, 2010

Selected photos from Cancer Immunotherapy: A Long-Awaited Reality conference hosted by MD Becker Partners and BioBusiness.TV held at the New York Academy of Medicine on October 21, 2010 (Note: Click on photo to enlarge).  Alternatively, click here to view a video montage of the conference photos.

Stem Cell Investor and Executive Networking Conference Event (SCIENCE)

Stem Cell Investor & Executive Networking Conference Event (SCIENCE), June 1, 2010

Selected photos from Stem Cell Investor and Executive Networking Conference Event (SCIENCE) hosted by MD Becker Partners and National Securities held in New York on June 1, 2010. Note: Click on photo to enlarge.

Cancer Vaccine Therapies: Failures and Future Opportunities

FIGURE 1: FDA APPROVAL OF CANCER MABS FROM 1997-2010

(Note: the following text is an Executive Summary from our new 150-page report titled “Cancer Vaccine Therapies: Failures and Future Opportunities”) Since the early 1990s, cancer immunotherapy has provided hope to patients, physicians, and investors as a new treatment modality with limited side effects and superior efficacy.  Cancer immunotherapy broadly includes passive immunization, active immunization, [...]

Biotech Stocks and the ASCO-effect

Cancer Cause Hiding in DNA Strand

Investors are hoping that the spark that could reignite investor enthusiasm for biotech stocks is taking place right now. Approximately 30,000 participants are gathering from May 29-June 2, 2009, in Orlando, Florida, for the year’s largest cancer conference. Attendees of the 45th Annual Meeting of the American Society of Clinical Oncology (ASCO) will exchange ideas [...]